{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:34:29Z","timestamp":1784892869449,"version":"3.55.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neurobiolaging.2021.07.017","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:28:21Z","timestamp":1627687701000},"page":"128-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Fatal attraction \u2013 The role of hypoxia when alpha-synuclein gets intimate with mitochondria"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-0151","authenticated-orcid":false,"given":"Johannes","family":"Burtscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Muazzam Kamil","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal A.","family":"Lashuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-4423","authenticated-orcid":false,"given":"Gr\u00e9goire P.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0002","doi-asserted-by":"crossref","first-page":"H756","DOI":"10.1152\/ajpheart.00725.2017","article-title":"Hypoxic conditioning in blood vessels and smooth muscle tissues: effects on function, mechanisms, and unknowns","volume":"315","author":"Almohanna","year":"2018","journal-title":"American journal of physiology. Heart and circulatory physiology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02537334","article-title":"Uptake of fatty acids by the developing rat brain","volume":"23","author":"Anderson","year":"1988","journal-title":"Lipids"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0004","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/1535370217712691","article-title":"Hypoxic conditioning and the central nervous system: A new therapeutic opportunity for brain and spinal cord injuries?","volume":"242","author":"Baillieul","year":"2017","journal-title":"Experimental biology and medicine (Maywood, N.J.)"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0005","doi-asserted-by":"crossref","first-page":"e00099-20","DOI":"10.1128\/MCB.00099-20","article-title":"The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Molecular and Cellular Biology"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0006","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophysical journal"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mds.27895","article-title":"The Vicious Cycle Between \u03b1-Synuclein Aggregation and Autophagic-Lysosomal Dysfunction","volume":"35","author":"Bellomo","year":"2020","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/brain\/awl357","article-title":"Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy","volume":"130","author":"Benarroch","year":"2007","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0009","doi-asserted-by":"crossref","first-page":"e62277","DOI":"10.1371\/journal.pone.0062277","article-title":"TOM40 mediates mitochondrial dysfunction induced by \u03b1-synuclein accumulation in Parkinson's disease","volume":"8","author":"Bender","year":"2013","journal-title":"PloS one"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0010","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nature neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0011","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmb.2009.05.066","article-title":"Multiple tight phospholipid-binding modes of \u03b1-synuclein revealed by solution NMR spectroscopy","volume":"390","author":"Bodner","year":"2009","journal-title":"Journal of molecular biology"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0013","first-page":"61","article-title":"Proton MR spectroscopy of the brain in 14 patients with Parkinson disease","volume":"16","author":"Bowen","year":"1995","journal-title":"American journal of neuroradiology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0014","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.neurobiolaging.2008.06.010","article-title":"Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease","volume":"31","author":"Brighina","year":"2010","journal-title":"Neurobiology of aging"},{"issue":"5545","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science (New York, N.Y.)"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0016","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.parkreldis.2015.05.015","article-title":"The association between infectious burden and Parkinson's disease: A case-control study","volume":"21","author":"Bu","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"7788","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1808-9","article-title":"Regulation of \u03b1-synuclein by chaperones in mammalian cells","volume":"577","author":"Burmann","year":"2020","journal-title":"Nature"},{"issue":"5999","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0018","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0019","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0110-20.2020","article-title":"Pronounced \u03b1-synuclein pathology in a seeding-based mouse model is not sufficient to induce mitochondrial respiration deficits in the striatum and amygdala","volume":"7","author":"Burtscher","year":"2020","journal-title":"Eneuro"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/ijms22020582","article-title":"A Rationale for Hypoxic and Chemical Conditioning in Huntington's Disease","volume":"22","author":"Burtscher","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0021","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mds.28544","article-title":"Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?","volume":"36","author":"Burtscher","year":"2021","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0022","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cne.23011","article-title":"Synuclein accumulation is associated with cell-specific neuronal death after spinal cord injury","volume":"520","author":"Busch","year":"2012","journal-title":"Journal of Comparative Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0023","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-2836(03)00520-5","article-title":"A structural and functional role for 11-mer repeats in \u03b1-synuclein and other exchangeable lipid binding proteins","volume":"329","author":"Bussell","year":"2003","journal-title":"Journal of molecular biology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-020-00988-w","article-title":"Hippocampal neurons respond to brain activity with functional hypoxia","author":"Butt","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0025","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1074\/jbc.M708477200","article-title":"Functional mitochondria are required for \u03b1-synuclein toxicity in aging yeast","volume":"283","author":"B\u00fcttner","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0026","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI129987","article-title":"Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases","volume":"129","author":"Cai","year":"2019","journal-title":"The Journal of clinical investigation"},{"issue":"7764","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","article-title":"From discoveries in ageing research to therapeutics for healthy ageing","volume":"571","author":"Campisi","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0028","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12035-020-02123-w","article-title":"Differential Regional Responses in Soluble Monomeric Alpha Synuclein Abundance Following Traumatic Brain Injury","volume":"58","author":"Carlson","year":"2021","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.arr.2016.04.009","article-title":"The crucial impact of lysosomes in aging and longevity","volume":"32","author":"Carmona-Gutierrez","year":"2016","journal-title":"Ageing research reviews"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2014.02.022","article-title":"\u03b4-Opioid receptor activation reduces \u03b1-synuclein overexpression and oligomer formation induced by MPP+ and\/or hypoxia","volume":"255","author":"Chen","year":"2014","journal-title":"Experimental neurology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0031","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s12035-018-1316-1","article-title":"delta-Opioid Receptor Activation Attenuates the Oligomer Formation Induced by Hypoxia and\/or alpha-Synuclein Overexpression\/Mutation Through Dual Signaling Pathways","volume":"56","author":"Chen","year":"2019","journal-title":"Molecular neurobiology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0032","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of \u03b1-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiology of disease"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0033","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbrc.2016.08.153","article-title":"Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness","volume":"483","author":"Cieri","year":"2017","journal-title":"Biochemical and biophysical research communications"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0034","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.yexcr.2008.03.012","article-title":"Mitochondrial translocation of \u03b1-synuclein is promoted by intracellular acidification","volume":"314","author":"Cole","year":"2008","journal-title":"Experimental cell research"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson's disease: Different sides of the same coin?","volume":"32","author":"Collier","year":"2017","journal-title":"Movement Disorders"},{"issue":"38","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0036","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.2174\/1381612811319380013","article-title":"Defective HIF signaling pathway and brain response to hypoxia in neurodegenerative diseases: not an \u201ciffy\u201d question!","volume":"19","author":"Correia","year":"2013","journal-title":"Current pharmaceutical design"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06443.x","article-title":"Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?","volume":"112","author":"Correia","year":"2010","journal-title":"Journal of neurochemistry"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0038","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41531-020-00139-6","article-title":"Protection from \u03b1-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20","volume":"6","author":"De Miranda","year":"2020","journal-title":"npj Parkinson's Disease"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1969.00480180071006","article-title":"Sphingomyelin in Lewy inclusion bodies in Parkinson's disease","volume":"21","author":"den Jager","year":"1969","journal-title":"Archives of neurology"},{"issue":"1-2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)01255-9","article-title":"MPP+-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport","volume":"715","author":"Desai","year":"1996","journal-title":"Brain research"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0042","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molmed.2019.10.009","article-title":"Mitochondria\u2013lysosome crosstalk: from physiology to neurodegeneration","volume":"26","author":"Deus","year":"2020","journal-title":"Trends in Molecular Medicine"},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0043","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"The Journal of biological chemistry"},{"issue":"342","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0044","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Science translational medicine"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","article-title":"Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease*\u2020","volume":"24","author":"Duffy","year":"1965","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0046","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"1325","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0047","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1039\/C8SM02133C","article-title":"Curvature sensing by cardiolipin in simulated buckled membranes","volume":"15","author":"El\u00edas-Wolff","year":"2019","journal-title":"Soft matter"},{"issue":"22","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0048","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1128\/MCB.25.22.10190-10201.2005","article-title":"Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking \u03b1-synuclein","volume":"25","author":"Ellis","year":"2005","journal-title":"Molecular and cellular biology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0049","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100942","article-title":"Shaping the nrf2-are-related pathways in alzheimer's and parkinson's diseases","volume":"54","author":"F\u00e3o","year":"2019","journal-title":"Ageing Research Reviews"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0051","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","article-title":"Reverse engineering Lewy bodies: how far have we come and how far can we go?","volume":"22","author":"Fares","year":"2021","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0052","first-page":"1","article-title":"Up-regulation of HIF-1\u03b1 is associated with neuroprotective effects of agmatine against rotenone-induced toxicity in differentiated SH-SY5Y cells","author":"Ferlazzo","year":"2019","journal-title":"Amino acids"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0053","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1570159X13666151030102718","article-title":"Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View","volume":"14","author":"Filograna","year":"2016","journal-title":"Current neuropharmacology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0054","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mds.25804","article-title":"Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy","volume":"29","author":"Flabeau","year":"2014","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","article-title":"Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage","volume":"135","author":"Fl\u00f8nes","year":"2018","journal-title":"Acta neuropathologica"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0056","doi-asserted-by":"crossref","first-page":"e20190086","DOI":"10.1084\/jem.20190086","article-title":"Effects of dietary restriction on neuroinflammation in neurodegenerative diseases","volume":"218","author":"Fontana","year":"2021","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0057","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00688674","article-title":"Ultrastructure of Lewy bodies in the stellate ganglion","volume":"34","author":"Forno","year":"1976","journal-title":"Acta neuropathologica"},{"issue":"30","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0058","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","article-title":"Lipid rafts mediate the synaptic localization of \u03b1-synuclein","volume":"24","author":"Fortin","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0059","doi-asserted-by":"crossref","first-page":"27125","DOI":"10.1038\/srep27125","article-title":"Structural ensembles of membrane-bound \u03b1-synuclein reveal the molecular determinants of synaptic vesicle affinity","volume":"6","author":"Fusco","year":"2016","journal-title":"Scientific reports"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","article-title":"In situ and in vitro study of colocalization and segregation of \u03b1-synuclein, ubiquitin, and lipids in Lewy bodies","volume":"166","author":"Gai","year":"2000","journal-title":"Experimental neurology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0061","series-title":"Proceedings of the National Academy of Sciences","first-page":"7065","article-title":"Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein","volume":"113","author":"Galvagnion","year":"2016"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0062","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nchembio.1750","article-title":"Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation","volume":"11","author":"Galvagnion","year":"2015","journal-title":"Nature chemical biology"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell death & disease"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0064","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.biopha.2017.11.057","article-title":"Morphological analysis of mitochondria for evaluating the toxicity of \u03b1-synuclein in transgenic mice and isolated preparations by atomic force microscopy","volume":"96","author":"Gao","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0065","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","article-title":"Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons","volume":"29","author":"Gegg","year":"2020","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0066","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1021\/acschemneuro.9b00320","article-title":"Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes","volume":"10","author":"Ghio","year":"2019","journal-title":"ACS chemical neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0067","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.plipres.2015.10.005","article-title":"Interaction of \u03b1-synuclein with biomembranes in Parkinson's disease\u2014role of cardiolipin","volume":"61","author":"Ghio","year":"2016","journal-title":"Progress in lipid research"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0068","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","article-title":"The cell biology of mitochondrial membrane dynamics","volume":"21","author":"Giacomello","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0069","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/mds.98","article-title":"What's wrong with mitochondria in Parkinson's disease?","volume":"33","author":"Greenamyre","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Grunewald","year":"2018","journal-title":"Progress in neurobiology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0071","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0072","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"alpha-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Guardia-Laguarta","year":"2014","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0073","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.26239","article-title":"A new role for \u03b1-synuclein in Parkinson's disease: Alteration of ER\u2013mitochondrial communication","volume":"30","author":"Guardia-Laguarta","year":"2015","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2016.03.016","article-title":"Deferoxamine-mediated up-regulation of HIF-1\u03b1 prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice","volume":"280","author":"Guo","year":"2016","journal-title":"Experimental neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/\u03b1-synuclein in vitro","volume":"10","author":"Hashimoto","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0076","doi-asserted-by":"crossref","unstructured":"Heras-Garvin, A., Danninger, C., Eschlb\u00f6ck, S., Holton, J.L., Wenning, G.K., Stefanova, N., 2020. Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in \u03b1-Synucleinopathies. Movement Disorders n\/a(n\/a).","DOI":"10.1002\/mds.28229"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0077","doi-asserted-by":"crossref","unstructured":"Hirsch, E.C., Standaert, D.G., 2020. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease. Movement Disorders n\/a(n\/a).","DOI":"10.1002\/mds.28075"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0078","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Progress in lipid research"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0079","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nature Reviews Neurology"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"\u03b1-Synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"The American journal of pathology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0081","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-019-01993-2","article-title":"Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity","volume":"137","author":"Hu","year":"2019","journal-title":"Acta neuropathologica"},{"issue":"5516","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0082","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0083","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-019-0259-8","article-title":"The hypoxia\u2013lactate axis tempers inflammation","volume":"20","author":"Ivashkiv","year":"2020","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0084","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbapap.2018.10.006","article-title":"Disruptive membrane interactions of alpha-synuclein aggregates","volume":"1867","author":"Iyer","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"issue":"5516","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0086","series-title":"Proceedings of the National Academy of Sciences","first-page":"8331","article-title":"Structure of membrane-bound \u03b1-synuclein studied by site-directed spin labeling","volume":"101","author":"Jao","year":"2004"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0087","series-title":"Proceedings of the National Academy of Sciences","first-page":"19666","article-title":"Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008"},{"issue":"6526","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0088","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.abb5916","article-title":"Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders","volume":"371","author":"Johmura","year":"2021","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0089","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Molecular cell"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chemphyslip.2013.11.010","article-title":"Cardiolipin asymmetry, oxidation and signaling","volume":"179","author":"Kagan","year":"2014","journal-title":"Chem Phys Lipids"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0091","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/1440-1681.13162","article-title":"Hypoxia-inducible factor 1 alpha and nuclear-related receptor 1 as targets for neuroprotection by albendazole in a rat rotenone model of Parkinson's disease","volume":"46","author":"Kandil","year":"2019","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0092","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1471-4159.1999.0732586.x","article-title":"Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury","volume":"73","author":"Kholodilov","year":"1999","journal-title":"J Neurochem"},{"issue":"26","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0094","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1523\/JNEUROSCI.1241-16.2016","article-title":"Poststroke induction of \u03b1-synuclein mediates ischemic brain damage","volume":"36","author":"Kim","year":"2016","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123444","article-title":"Alpha-synuclein levels in blood plasma decline with healthy aging","volume":"10","author":"Koehler","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0096","series-title":"Intermittent hypoxia: from molecular mechanisms to clinical applications","first-page":"549","article-title":"Parkinson's disease and intermittent hypoxia training","author":"Kolesnikova","year":"2009"},{"issue":"4587","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0097","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0098","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nature reviews. Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0099","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101660","article-title":"Mitochondrial Degradation of Amyloidogenic Proteins\u2014A New Perspective for Neurodegenerative Diseases","author":"Lautensch\u00e4ger","year":"2019","journal-title":"Progress in neurobiology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0100","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA119.011650","article-title":"Intramitochondrial proteostasis is directly coupled to \u03b1-synuclein and amyloid \u03b2 1-42 pathologies","author":"Lautenschl\u00e4ger","year":"2020","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0101","first-page":"1","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","author":"Lee","year":"2020","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"14","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0102","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1096\/fj.06-5097fje","article-title":"Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury","volume":"20","author":"Leonard","year":"2006","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0103","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnagi.2018.00121","article-title":"Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function","volume":"10","author":"Li","year":"2018","journal-title":"Frontiers in aging neuroscience"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0104","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1074\/jbc.M109.061051","article-title":"The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition","volume":"285","author":"Loeb","year":"2010","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nn.4529","article-title":"alpha-Synuclein promotes dilation of the exocytotic fusion pore","volume":"20","author":"Logan","year":"2017","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0106","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.freeradbiomed.2017.04.026","article-title":"Neurovascular-neuroenergetic coupling axis in the brain: master regulation by nitric oxide and consequences in aging and neurodegeneration","volume":"108","author":"Louren\u00e7o","year":"2017","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat Commun"},{"issue":"41","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0108","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1523\/JNEUROSCI.1659-16.2016","article-title":"Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase","volume":"36","author":"Ludtmann","year":"2016","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0109","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"4971","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020"},{"issue":"6863","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","article-title":"Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression","volume":"414","author":"Makino","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0111","series-title":"Hypoxic\u2013hyperoxic conditioning and dementia, Diagnosis and Management in Dementia","first-page":"745","author":"Mallet","year":"2020"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0112","article-title":"The application of low-level laser therapy for the symptomatic care of late stage Parkinson's disease: a non-controlled, non-randomized study","volume":"42","author":"Maloney","year":"2010","journal-title":"Lasers in Surgery And Medicine"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0113","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41467-021-21027-4","article-title":"The docking of synaptic vesicles on the presynaptic membrane induced by \u03b1-synuclein is modulated by lipid composition","volume":"12","author":"Man","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0114","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/1535370216649060","article-title":"Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease","volume":"241","author":"Manukhina","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0115","series-title":"Proceedings of the National Academy of Sciences","first-page":"6741","article-title":"Disruption of cellular proteostasis by H1N1 influenza A virus causes \u03b1-synuclein aggregation","volume":"117","author":"Marreiros","year":"2020"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0116","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.neurobiolaging.2013.11.008","article-title":"The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant \u03b1-synuclein transgenic mice","volume":"35","author":"Martin","year":"2014","journal-title":"Neurobiology of aging"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0117","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/pro.149","article-title":"Charge neutralization and collapse of the C-terminal tail of alpha-synuclein at low pH","volume":"18","author":"McClendon","year":"2009","journal-title":"Protein Sci"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0118","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","article-title":"The Role of HIF in Immunity and Inflammation","volume":"32","author":"McGettrick","year":"2020","journal-title":"Cell met."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0119","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00221-016-4836-9","article-title":"Impairment of mitochondria dynamics by human A53T alpha-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease","volume":"235","author":"Melo","year":"2017","journal-title":"Experimental brain research"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0120","doi-asserted-by":"crossref","first-page":"42942","DOI":"10.1038\/srep42942","article-title":"Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress","volume":"7","author":"Menges","year":"2017","journal-title":"Scientific reports"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0121","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","article-title":"Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles","volume":"99","author":"Middleton","year":"2010","journal-title":"Biophysical journal"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.580634","article-title":"The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson's Disease","volume":"8","author":"Minakaki","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ana.21613","article-title":"Decreased ventilatory response to hypercapnia in dementia with Lewy bodies","volume":"65","author":"Mizukami","year":"2009","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0124","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e3182904d43","article-title":"\u03b1-Synuclein in CSF of patients with severe traumatic brain injury","volume":"80","author":"Mondello","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0125","article-title":"The interplay between GCase, \u03b1-synuclein and lipids in human models of Parkinson's disease","volume":"273","author":"Mu\u00f1oz","year":"2020","journal-title":"Biophysical Chemistry"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0126","doi-asserted-by":"crossref","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","article-title":"Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein","volume":"286","author":"Nakamura","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"47","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0127","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1523\/JNEUROSCI.3088-08.2008","article-title":"Optical reporters for the conformation of \u03b1-synuclein reveal a specific interaction with mitochondria","volume":"28","author":"Nakamura","year":"2008","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0128","series-title":"Paraquat-and rotenone-induced models of Parkinson's disease","author":"Nistic\u00f2","year":"2011"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0129","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1074\/jbc.M401076200","article-title":"\u03b1-Synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study","volume":"279","author":"Nuscher","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0130","article-title":"Fatty acyl availability modulates cardiolipin composition and alters mitochondrial function in HeLa cells","author":"Oemer","year":"2020","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0131","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1016\/j.celrep.2020.02.115","article-title":"Phospholipid Acyl Chain Diversity Controls the Tissue-Specific Assembly of Mitochondrial Cardiolipins","volume":"30","author":"Oemer","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0132","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"4158","article-title":"Molecular structural diversity of mitochondrial cardiolipins","volume":"115","author":"Oemer","year":"2018"},{"issue":"9231","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0133","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(00)02638-6","article-title":"Impaired chemosensitivity and perception of dyspnoea in Parkinson's disease","volume":"356","author":"Onodera","year":"2000","journal-title":"The Lancet"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0134","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","article-title":"The A53T \u03b1-synuclein mutation increases iron-dependent aggregation and toxicity","volume":"20","author":"Ostrerova-Golts","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0135","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.cdd.4402135","article-title":"Role of cardiolipin in cytochrome c release from mitochondria","volume":"14","author":"Ott","year":"2007","journal-title":"Cell death and differentiation"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0136","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Current Biology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","article-title":"\u03b1-Synuclein binds to the ER\u2013mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production","volume":"134","author":"Paillusson","year":"2017","journal-title":"Acta neuropathologica"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0138","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","article-title":"Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage","volume":"26","author":"Paiva","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0139","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"Paradies","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Bioenergetics"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0140","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/cells8070728","article-title":"Role of cardiolipin in mitochondrial function and dynamics in health and disease: Molecular and pharmacological aspects","volume":"8","author":"Paradies","year":"2019","journal-title":"Cells"},{"issue":"7-8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0141","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","article-title":"Mitochondrial association of alpha-synuclein causes oxidative stress","volume":"65","author":"Parihar","year":"2008","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0142","article-title":"Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits","author":"Peelaerts","year":"2020","journal-title":"bioRxiv"},{"issue":"44","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0143","doi-asserted-by":"crossref","first-page":"34393","DOI":"10.1074\/jbc.M004851200","article-title":"Interaction of human \u03b1-synuclein and Parkinson's disease variants with phospholipids structural analysis using site-directed mutagenesis","volume":"275","author":"Perrin","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0144","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27878","article-title":"Systemic activation of Nrf2 pathway in Parkinson's disease","volume":"35","author":"Petrillo","year":"2020","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbamem.2011.07.032","article-title":"Biophysics of \u03b1-synuclein membrane interactions","volume":"1818","author":"Pfefferkorn","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"52","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0146","doi-asserted-by":"crossref","first-page":"52873","DOI":"10.1074\/jbc.M308366200","article-title":"Cardiolipin stabilizes respiratory chain supercomplexes","volume":"278","author":"Pfeiffer","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0147","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbamem.2015.06.021","article-title":"\u03b1-Synuclein interactions with phospholipid model membranes: Key roles for electrostatic interactions and lipid-bilayer structure","volume":"1848","author":"Pirc","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0148","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1038\/s41598-017-05334-9","article-title":"\u03b1Synuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease","volume":"7","author":"Pozo Devoto","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0149","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dmm.026294","article-title":"Mitochondrial dynamics in Parkinson's disease: a role for alpha-synuclein?","volume":"10","author":"Pozo Devoto","year":"2017","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5665\/sleep.3418","article-title":"Degeneration of Brainstem Respiratory Neurons in Dementia with Lewy Bodies","volume":"37","author":"Presti","year":"2014","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0151","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s10072-019-03905-4","article-title":"Association of HIF1A and Parkinson's disease in a Han Chinese population demonstrated by molecular inversion probe analysis","volume":"40","author":"Qin","year":"2019","journal-title":"Neurological Sciences"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0152","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"\u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nature Chemistry"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0153","doi-asserted-by":"crossref","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","article-title":"Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons","volume":"6","author":"Reeve","year":"2015","journal-title":"Cell death & disease"},{"issue":"100","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0154","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2014.04.001","article-title":"Metabolism and function of mitochondrial cardiolipin","volume":"55","author":"Ren","year":"2014","journal-title":"Prog Lipid Res"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0156","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1212\/WNL.0000000000006777","article-title":"Hypoxemia following generalized convulsive seizures: risk factors and effect of oxygen therapy","volume":"92","author":"Rheims","year":"2019","journal-title":"Neurology"},{"issue":"7645","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0157","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature21695","article-title":"Cytosolic proteostasis through importing of misfolded proteins into mitochondria","volume":"543","author":"Ruan","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0158","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41467-018-03241-9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates \u03b1-synuclein","volume":"9","author":"Ryan","year":"2018","journal-title":"Nature communications"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0159","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.brs.2019.02.009","article-title":"Photobiomodulation in Parkinson's disease: A randomized controlled trial","volume":"12","author":"Santos","year":"2019","journal-title":"Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0161","doi-asserted-by":"crossref","unstructured":"Schaser, A.J., Osterberg, V.R., Dent, S.E., Stackhouse, T.L., Wakeham, C.M., Boutros, S.W., Weston, L.J., Owen, N., Weissman, T.A., Luna, E., Raber, J., Luk, K.C., McCullough, A.K., Woltjer, R.L., Unni, V.K., 2019. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders, Scientific reports. p. 10919.","DOI":"10.1038\/s41598-019-47227-z"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0162","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbalip.2012.11.007","article-title":"Cardiolipin remodeling and the function of tafazzin","volume":"1831","author":"Schlame","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0163","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/brain\/awq327","article-title":"Neuroanatomical characteristics of the human pre-B\u00f6tzinger complex and its involvement in neurodegenerative brainstem diseases","volume":"134","author":"Schwarzacher","year":"2011","journal-title":"Brain"},{"issue":"35","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0164","doi-asserted-by":"crossref","first-page":"eabb0780","DOI":"10.1126\/sciadv.abb0780","article-title":"Cardiolipin, conformation, and respiratory complex-dependent oligomerization of the major mitochondrial ADP\/ATP carrier in yeast","volume":"6","author":"Senoo","year":"2020","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000029224","article-title":"Hypoxic ventilatory responses and gas exchange in patients with Parkinson's disease","volume":"65","author":"Serebrovskaya","year":"1998","journal-title":"Respiration; international review of thoracic diseases"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0166","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418781889","article-title":"Sex-related abnormalities in substantia nigra lipids in Parkinson's disease","volume":"10","author":"Seyfried","year":"2018","journal-title":"ASN neuro"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0167","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nature neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0168","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00401-018-1873-4","article-title":"Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson's models","volume":"136","author":"Shaltouki","year":"2018","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110373","article-title":"Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease","volume":"129","author":"Sharma","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2014.09.046","article-title":"\u03b1-Synuclein amino terminus regulates mitochondrial membrane permeability","volume":"1591","author":"Shen","year":"2014","journal-title":"Brain research"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0171","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0172","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1111\/acel.12941","article-title":"Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson's diseases","volume":"18","author":"Song","year":"2019","journal-title":"Aging cell"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0173","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrneurol.2011.107","article-title":"How might physical activity benefit patients with Parkinson disease?","volume":"7","author":"Speelman","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0174","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4899-7678-9_16","article-title":"Hypoxic Adaptation in the Nervous System: Promise for Novel Therapeutics for Acute and Chronic Neurodegeneration","volume":"903","author":"Speer","year":"2016","journal-title":"Advances in experimental medicine and biology"},{"issue":"6645","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0176","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1073858410366481","article-title":"Nitric oxide signaling in brain function, dysfunction, and dementia","volume":"16","author":"Steinert","year":"2010","journal-title":"Neuroscientist"},{"issue":"10-11","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0177","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00702-004-0203-2","article-title":"Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration","volume":"111","author":"Storch","year":"2004","journal-title":"Journal of neural transmission"},{"issue":"5-6","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0178","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000321342","article-title":"\u03b1-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia","volume":"32","author":"Su","year":"2010","journal-title":"Developmental neuroscience"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0179","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.14810","article-title":"The Physiological Role of alpha-Synuclein and Its Relationship to Parkinson's Disease","volume":"150","author":"Sulzer","year":"2019","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0180","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/acn3.756","article-title":"Plasma \u03b1-synuclein levels are increased in patients with obstructive sleep apnea syndrome","volume":"6","author":"Sun","year":"2019","journal-title":"Annals of clinical and translational neurology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0181","series-title":"Hypoxia: Translation in Progress","first-page":"301","article-title":"Hypoxia and Its Acid\u2013Base Consequences: From Mountains to Malignancy","author":"Swenson","year":"2016"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0182","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3940(97)00676-9","article-title":"Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"234","author":"Takeda","year":"1997","journal-title":"Neuroscience letters"},{"issue":"15","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0183","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","article-title":"Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production","volume":"74","author":"Tapias","year":"2017","journal-title":"Cellular and molecular life sciences: CMLS"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0184","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091914","article-title":"Comparative Response of Brain to Chronic Hypoxia and Hyperoxia","volume":"18","author":"Terraneo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0404.1989.tb01780.x","article-title":"MPTP-induced parkinsonism as a model for Parkinson's disease","volume":"126","author":"Tetrud","year":"1989","journal-title":"Acta neurologica Scandinavica. Supplementum"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0186","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson's disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0187","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00581.2016","article-title":"Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging","volume":"312","author":"Toth","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0188","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/antiox6020027","article-title":"Strange bedfellows: nuclear factor, erythroid 2-like 2 (Nrf2) and hypoxia-inducible factor 1 (HIF-1) in tumor hypoxia","volume":"6","author":"Toth","year":"2017","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0189","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.10296","article-title":"Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy","volume":"52","author":"Tsuda","year":"2002","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble \u03b1-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Annals of neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0191","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nchem.1924","article-title":"A mitochondrial pathway for biosynthesis of lipid mediators","volume":"6","author":"Tyurina","year":"2014","journal-title":"Nat Chem"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0192","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.040899","article-title":"Misfolded \u03b1-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells","volume":"13","author":"Ugalde","year":"2020","journal-title":"Disease models & mechanisms"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0193","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","article-title":"The role of lipids in alpha-synuclein misfolding and neurotoxicity","volume":"294","author":"Ugalde","year":"2019","journal-title":"The Journal of biological chemistry"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0194","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human alpha-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jcbfm.2010.170","article-title":"Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse","volume":"31","author":"Unal-Cevik","year":"2011","journal-title":"Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"1-3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(02)02446-8","article-title":"Accelerated \u03b1-synuclein fibrillation in crowded milieu","volume":"515","author":"Uversky","year":"2002","journal-title":"FEBS letters"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101108","article-title":"Exercise benefits on Alzheimer's disease: State-of-the-science","volume":"62","author":"Valenzuela","year":"2020","journal-title":"Ageing research reviews"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0198","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101267","article-title":"To breathe or not to breathe: Understanding how oxygen sensing contributes to age-related phenotypes","volume":"67","author":"van Vliet","year":"2021","journal-title":"Ageing research reviews"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0199","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fphar.2019.00033","article-title":"Nrf2\/ARE pathway modulation by dietary energy regulation in neurological disorders","volume":"10","author":"Vasconcelos","year":"2019","journal-title":"Frontiers in pharmacology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101729","article-title":"A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges","volume":"185","author":"Vasquez","year":"2020","journal-title":"Progress in neurobiology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0201","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fnins.2018.00388","article-title":"The close encounter between alpha-synuclein and mitochondria","volume":"12","author":"Vicario","year":"2018","journal-title":"Frontiers in neuroscience"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41419-019-2092-1","article-title":"A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein","volume":"10","author":"Vicario","year":"2019","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mds.27932","article-title":"Brainstem Ventilatory Dysfunction: A Plausible Mechanism for Dyspnea in Parkinson's Disease?","volume":"35","author":"Vijayan","year":"2020","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0204","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"\u03b1-Synuclein Up-Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"Journal of neurochemistry"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1083\/jcb.201511044","article-title":"Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency","volume":"216","author":"Vos","year":"2017","journal-title":"The Journal of cell biology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0207","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2015.05.008","article-title":"TNF compromises lysosome acidification and reduces \u03b1-synuclein degradation via autophagy in dopaminergic cells","volume":"271","author":"Wang","year":"2015","journal-title":"Experimental neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","article-title":"Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration","volume":"7","author":"Wang","year":"2019","journal-title":"Acta neuropathologica communications"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0209","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/mds.27823","article-title":"Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?","volume":"34","author":"Wong","year":"2019","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mcn.2013.01.004","article-title":"Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity","volume":"54","author":"Xiang","year":"2013","journal-title":"Molecular and Cellular Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0211","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101090","article-title":"Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice","volume":"21","author":"Xu","year":"2019","journal-title":"Redox biology"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00197-z","article-title":"Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation","volume":"9","author":"Yang","year":"2020","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0213","article-title":"Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia","volume":"120","author":"Yang","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology, ATVBAHA"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0214","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S1353-8020(13)70032-4","article-title":"Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease","volume":"20","author":"Youdim","year":"2014","journal-title":"Parkinsonism & related disorders"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0215","first-page":"263","article-title":"Effect of repeated acute hypoxic treatment on the expression of alpha-synuclein in the mouse brain cortex","volume":"56","author":"Yu","year":"2004","journal-title":"ACTA PHYSIOLOGICA SINICA-CHINESE EDITION"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2021.07.017_bib0216","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1074\/jbc.M210136200","article-title":"Lipid binding inhibits \u03b1-synuclein fibril formation","volume":"278","author":"Zhu","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neurobiolaging.2021.07.017_bib0217","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal Biochem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:40:34Z","timestamp":1759318834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":215,"alternative-id":["S0197458021002438"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.07.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal attraction \u2013 The role of hypoxia when alpha-synuclein gets intimate with mitochondria","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}